Collaborations

Print

Collaborations

GlobeImmune currently has collaboration agreements with:

  • Celgene Corporation¬† for the development of GlobeImmune‚Äôs oncology Tarmogens
  • Gilead Sciences, Inc. for the development of hepatitis B virus (HBV) Tarmogens

GlobeImmune plans to seek third-party collaborators for the development of certain other Tarmogen product candidates.